Is the price fair?
What ITGR's price assumes
Integer Holdings Corporation trades at 31.3× earnings against 33.4× for the median Medical Devices name, cheaper than its own group.
31.3
Trailing P/E · Medical Devices median 33.4 · cheaper than the typical name in its group
- Price / sales
- 1.61
Price / sales · as of 2026-Q1
- Free cash flow yield
- 3.2%
Free cash flow yield · Medical Devices median 4.0%
- Growth the price implies
- +11%
Growth the price implies · The price pays for +11% free cash flow growth a year for a decade; the business has delivered +85% a year over the last three.
Details›
- Price / book2026-Q1
- 1.76
- EV / EBIT2026-Q1
- 20.8
- EV / sales2026-Q1
- 2.28
- Healthcare median P/E362 names
- 31.5
- Medical Devices median P/E39 names
- 33.4
- Free cash flow, trailing twelve months
- $100M
- Market capitalisation
- $3.09B
- 3-year revenue growth
- +9.9%
- 3-year free cash flow growth
- +85%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $125.12 |
| Its own P/E history, median | $145.42 |
| Its own P/E history, upper quartile | $155.21 |
| 52-week range | $63.32 – $125.97 |
| Today | $125.26 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.